"Polyethylene Glycols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS.
| Descriptor ID |
D011092
|
| MeSH Number(s) |
D02.033.455.250.700 D05.750.741 D25.720.741 J01.637.051.720.741
|
| Concept/Terms |
Polyethylene Glycols- Polyethylene Glycols
- Macrogols
- Macrogol
- Polyethylene Glycol
- Glycol, Polyethylene
- Glycols, Polyethylene
- Polyethylene Oxide
- Oxide, Polyethylene
- Oxides, Polyethylene
- Polyethylene Oxides
- Polyethyleneoxide
- Polyethyleneoxides
- Polyoxyethylenes
- Polyoxyethylene
- Tritons
|
Below are MeSH descriptors whose meaning is more general than "Polyethylene Glycols".
Below are MeSH descriptors whose meaning is more specific than "Polyethylene Glycols".
This graph shows the total number of publications written about "Polyethylene Glycols" by people in this website by year, and whether "Polyethylene Glycols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 1 | 3 |
| 2015 | 0 | 3 | 3 |
| 2016 | 3 | 2 | 5 |
| 2017 | 0 | 3 | 3 |
| 2018 | 2 | 1 | 3 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 2 | 2 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Polyethylene Glycols" by people in Profiles.
-
A549 Alveolar Carcinoma Spheroids as a Cytotoxicity Platform for Carboxyl- and Amine-Polyethylene Glycol Gold Nanoparticles. Pharmacol Res Perspect. 2025 Feb; 13(1):e70051.
-
Computational study of the effect of size and surface functionalization on Au nanoparticles on their stability to study biological descriptors. J Mol Model. 2022 Nov 03; 28(11):376.
-
In vitro toxicity and internalization of gold nanoparticles (AuNPs) in human epithelial colorectal adenocarcinoma (Caco-2) cells and the human skin keratinocyte (HaCaT) cells. Mutat Res Genet Toxicol Environ Mutagen. 2022 Nov-Dec; 883-884:503556.
-
Fouling in ocular devices: implications for drug delivery, bioactive surface immobilization, and biomaterial design. Drug Deliv Transl Res. 2021 10; 11(5):1903-1923.
-
The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing. Lancet. 2021 02 13; 397(10274):630-640.
-
Hepatitis C infection at a tertiary hospital in South Africa: Clinical presentation, non-invasive assessment of liver fibrosis, and response to therapy. S Afr Med J. 2020 Aug 31; 110(9):920-925.
-
Folate-decorated, endostatin-loaded, nanoparticles for anti-proliferative chemotherapy in esophaegeal squamous cell carcinoma. Biomed Pharmacother. 2019 Nov; 119:109450.
-
Differences in uptake of 14 nm PEG-liganded gold nanoparticles into BEAS-2B cells is dependent on their functional groups. Toxicol Appl Pharmacol. 2019 01 15; 363:131-141.
-
Once-weekly prophylaxis with 40 IU/kg nonacog beta pegol (N9-GP) achieves trough levels of >15% in patients with haemophilia B: Pooled data from the paradigm™ trials. Haemophilia. 2018 Nov; 24(6):911-920.
-
Dexamethasone-Loaded, PEGylated, Vertically Aligned, Multiwalled Carbon Nanotubes for Potential Ischemic Stroke Intervention. Molecules. 2018 06 10; 23(6).